5 citations
,
January 2018 in “Skin Research and Technology” This letter compares automated digital image analysis (TrichoScan) with manual marking of hairs in male patients with androgenetic alopecia but reports no new results.
5 citations
,
July 2024 in “International Journal of Women’s Dermatology” This study suggests that using patient-specific products and individualized patch testing can improve the accuracy of diagnosing scalp allergic contact dermatitis in women.
4 citations
,
May 2022 in “Frontiers in Medicine” The authors concluded that trichoscopic examination can be useful for diagnosing syphilitic alopecia in patients with idiopathic alopecia, though the findings are nonspecific and further studies are needed.
4 citations
,
March 2016 in “Turkish Journal of Dermatology” This study reported that androgenetic alopecia, telogen effluvium, and alopecia areata were the most common hair diseases among patients attending a hair diseases unit in their region.
3 citations
,
January 2022 in “Anais Brasileiros De Dermatologia” This study suggests that pediatric androgenetic alopecia is often associated with metabolic syndrome risk factors, highlighting the importance of early diagnosis for potential future health complications.
3 citations
,
January 2021 in “Skin appendage disorders” This study reports anagen hair loss four weeks after scalp surgeries, likely due to transient ischemia, and emphasizes the importance of informing patients about potential hair loss and recovery within three months.
2 citations
,
April 2021 in “Journal of The American Academy of Dermatology” This study found that female pattern hair loss was highly prevalent among a multiracial Brazilian population, affecting over 30% of women, and age was a significant risk factor.
2 citations
,
July 2024 in “Journal of Clinical Medicine” In this study, telemedicine using trichoscopy for alopecia areata patients showed high concordance with outpatient trichoscopy in image quality and similar levels of patient satisfaction, indicating its effectiveness for follow-up and continuity of care.
1 citations
,
January 2017 in “International Journal of Dermoscopy” This study found that trichoscopic digital imaging is a safe and accurate method for assessing the donor area in patients undergoing hair transplantation, helping to plan graft utilization based on hair density and follicular unit measurements.
1 citations
,
May 2019 in “Journal of The European Academy of Dermatology and Venereology” New method, hair distribution width (HDW), improves accuracy in diagnosing androgenetic alopecia (AGA).
This study highlights the lack of direct evidence to differentiate between alopecia areata and androgenic alopecia but underscores the importance of clinical, trichoscopic, and histopathologic evaluations for accurate diagnosis, particularly when symptoms overlap.
July 2026 in “Journal of Dermatological Treatment” In this randomized trial of Iranian men with moderate to severe androgenetic alopecia, researchers found that both finasteride and dutasteride improved hair density over 24 weeks, with dutasteride showing stronger PSA reduction but similar safety to finasteride.
June 2026 in “Skin Appendage Disorders” This study suggests that pili annulati is likely more common than traditionally thought, highlighting the importance of recognizing its characteristic clinical and trichoscopic features for accurate diagnosis.
This study consolidates information on the unique structural and functional biology of Indian hair, reporting distinct scalp microbial ecology and trichoscopic parameters, which are important for diagnosing and treating hair conditions in Indian populations.
April 2026 in “Academic Dermatology” In this retrospective observational study, researchers found that the Dean Scale showed better diagnostic accuracy than the CTCAE scale for detecting clinician-reported therapeutic responses to minoxidil in patients with anticancer therapy-induced alopecia, but both scales had limitations in recording clinically significant hair regrowth.
March 2026 in “Reports of Vinnytsia National Medical University” This study examined young Ukrainian men with alopecia areata and found that different severities of the condition were associated with distinct clinical and trichoscopic features, such as variations in hair loss, stress levels, and nail involvement, among others.
January 2026 in “Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)” This study observed that baricitinib led to significant hair regrowth and improved psychological well-being in severe alopecia areata patients over 48 weeks, with 63.2% achieving a SALT score of ≤20.
January 2026 in “Dermatologic Therapy” This study found that combining ablative fractional CO2 laser treatment with topical minoxidil significantly improved frontal hairline regrowth and patient satisfaction in men with androgenetic alopecia compared to using minoxidil alone, without serious adverse effects.
December 2025 in “Journal of Paediatrics and Child Health” This study highlights that careful interpretation of bite-centered anatomy and trichoscopic signs can help differentiate tick-bite alopecia from alopecia areata in children, with specific management strategies based on clinical signs.
September 2025 in “PubMed” In this study, researchers observed diffuse hair loss in Japanese patients post-hematopoietic stem cell transplantation and chemotherapy, with treatments targeting hair follicle miniaturization, like topical minoxidil, improving hair volume in about 52.9% of cases.
September 2025 in “Journal of the European Academy of Dermatology and Venereology” This real-world study found that baricitinib 4 mg daily was effective in promoting hair regrowth and improving psychological well-being in Italian adults with severe alopecia areata over 48 weeks, with 63.2% of patients achieving significant hair recovery and 9.4% experiencing adverse events.
September 2025 in “Dermatologic Surgery” This study found that combining Fractional Microneedling Radiofrequency (FMRF) with topical minoxidil significantly increased hair counts and density more than minoxidil alone or combined with Fractional CO2 in women with androgenic alopecia.
July 2025 in “INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH” In this observational study, researchers found that alopecia areata is associated with specific trichoscopic features, such as black dots, yellow dots, and vellus hair, and highlighted trichoptilosis as a potential overlap feature with other hair disorders, suggesting a need for further differentiation between these conditions.
July 2025 in “Clinical Medicine” In this institution-based randomized trial, oral betamethasone mini-pulse therapy for alopecia areata showed a faster therapeutic response compared to oral tofacitinib, as measured by trichoscopic changes and achievement of 50% hair regrowth.
June 2025 in “Italian Journal of Dermatology and Venereology” In this study, researchers characterized alopecia areata incognita in men, finding that all 29 male patients had concurrent androgenetic alopecia, and treatment with ultra-potent topical corticosteroids and minoxidil led to remission in 4-8 months.
April 2025 in “British Journal of Dermatology” This study identified three genetic loci influencing hair density in East Asian populations and found associations with demographic and lifestyle factors like age, sex, and BMI. The results also suggest possible genotype-specific responses to finasteride for managing hair disorders.
February 2025 in “Dermatology and Therapy” This study highlights alopecia areata incognita as a unique form of alopecia areata that shares features with telogen effluvium and may relate to androgenetic alopecia, noting its sudden onset and favorable response to topical steroids.
January 2025 in “Dermatologic Therapy” This study found that adding low-dose oral minoxidil to standard treatment for lichen planopilaris was safe but did not significantly improve hair density or thickness, although minor hair regrowth was observed in some scarring areas.
November 2024 in “Journal of Investigative Dermatology” This study found that scarring alopecia is common in autosomal recessive congenital ichthyosis patients and significantly correlates with the disease's severity, highlighting the need for thorough hair evaluations in clinical management.
June 2024 in “Дерматовенерология Косметология” In this study, treatment with autologous follicular stem cells improved hair conditions in 57% of patients with androgenic and telogen effluvium alopecia, as confirmed by phototrichograms, indicating its potential effectiveness for non-scarring alopecia.